New York Congressman Collins indicted for insider trading of biotech stocks

Amy Baxter | | Health Exec | Management
Stocks

Rep. Chris Collins, R-New York, has been indicted on charges of insider trading related to his holdings in biotechnology stocks.

Collins, who served on the board of directors of Australian company Innate Immunotherapeutics, possessed nonpublic information and shared it with his son and others, including his son’s fiancée’s father, the U.S. Department of Justice alleges. Collins provided a tip about the results of an upcoming drug trial before it was public, saving the Congressman’s son, Cameron Collins, and the father of Cameron Collin’s fiancée, Stephen Zarsky, approximately $768,000.

Furthermore, the three allegedly made false statements to the FBI to cover up their participation in inside trading. All three are charged with conspiracy, securities fraud, wire fraud and making false statements to the FBI. All three have pleaded not guilty.

Collins was the first Republican in Congress to support President Donald Trump’s candidacy and is known for being loose-lipped with the media, Vox reported.

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Asante Medical facing $488M in lawsuits after fentanyl diversion linked to 16 deaths
FDA issues Class I alert on Philips ventilators after 4 injuries
Trump selects Emmy-winning TV personality Dr. Oz to head CMS
FDA issues Class I recall of infusion pump batteries due to risk of burns
Ransomware group deploys ticking clock to threaten Georgia hospital
Private equity transactions in healthcare down 15% since 2023, report finds

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup